The influence of EGFRvIII structure and its cellular distribution heterogeneity on designing new therapeutic and diagnostic approaches

2019/35/B/NZ3/03577

Keywords

Descriptors

  • NZ3_001: Biologia komórki
  • NZ1_001: Biologia molekularna
  • NZ7_014: Farmacja, farmakoterapia, farmakologia

Panel

NZ3 – Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology

Host institution

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Voivodeship: łódzkie

Other projects carried out by the institution »

Principal investigator (from the host institution)

prof. Piotr Rieske

Number of co-investigators in the project: 6

Call

OPUS 18 – announced on 2019-09-16

Amount awarded
1 608 840 PLN
Project start date
2020-07-27
Project end date
2025-01-26
Project duration
54 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (4)

  1. Phenotypical Flexibility of the EGFRvIII-Positive Glioblastoma Cell Line and the Multidirectional Influence of TGFβ and EGF on These Cells-EGFRvIII Appears as a Weak Oncogene

    Authors:
    Aneta Włodarczyk, Cezary Tręda, Adrianna Rutkowska,Dagmara Grot,Weronika Dobrewa Amelia Kierasińska,Marta Węgierska , Tomasz Wasiak , Tadeusz Strózik ,Piotr Rieske Ewelina Stoczyńska-Fidelus
    Academic press:
    International Journal of Molecular Sciences (year: 2022, volume: 23 (20), pages: nie dotyczy), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms232012129 – link to the publication
  2. Application and Design of Switches Used in CAR

    Authors:
    Paweł Głowacki, Piotr Rieske
    Academic press:
    Cells (year: 2022, volume: 11(12), pages: nie dotyczy), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/cells11121910 – link to the publication
  3. Immunohistochemical detection of EGFRvIII in glioblastoma - Anti-EGFRvIII antibody validation for diagnostic and CAR-T purposes

    Authors:
    Adrianna Rutkowska, Tadeusz Strózik , Krystyna Jędrychowska-Dańska , Alicja Zamerska , Dorota Jesionek-Kupnicka , Tamara Kowalczyk , Waldemar Och , Błażej Szóstak , Cezary Tręda , Aneta Włodarczyk , Amelia Kierasińska-Kałka , Tomasz Wasiak , Damian Ciunowicz Piotr Rieske , Ewelina Stoczyńska-Fidelus
    Academic press:
    Biochem Biophys Res Commun (year: 2023, volume: 685, pages: brak numerów stron), Publisher: Science Direct
    Status:
    Published
    DOI:
    10.1016/j.bbrc.2023.149133 – link to the publication
  4. Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy

    Authors:
    Cezary Tręda , Aneta Włodarczyk , Marcin Pacholczyk, Adrianna Rutkowska, Ewelina Stoczyńska-Fidelus, Amelia Kierasińska , Piotr Rieske
    Academic press:
    International Journal of Molecular Sciences (year: 2023, volume: 24(5), pages: nie dotyczy), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms24054350 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski